Clinical Trials on Submandibular Gland Neoplasms

Total 133362 results

Pfizer

Completed

Study Evaluating The Safety, Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington's Disease

Huntington's Disease

France
Ohio State University
Lundbeck LLC

Completed

Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease

Huntington's Disease

United States
Pfizer

Completed

Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease

Huntington's Disease

United States, Germany, United Kingdom, Canada, Poland
Assistance Publique - Hôpitaux de Paris

Completed

MIG-HD: Multicentric Intracerebral Grafting in Huntington's Disease (MIG-HD)

Huntington Disease

France
Jae-Kwan Song

Unknown

Device Closure Versus Medical Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale (DEFENSE-PFO)

Patent Foramen Ovale

Korea, Republic of
GlaxoSmithKline

Completed

Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease

Huntington Disease

United Kingdom
GlaxoSmithKline

Completed

A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278

Huntington Disease

Netherlands
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; University... and other collaborators

Unknown

Beta Testing of a New Assessment in Huntington's Disease (HD) (CAPIT-HD Beta)

Huntington Disease

France
Biogen

Completed

A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis (MOTION - JAPAN)

Multiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent Progressive

Japan
Institut National de la Santé Et de la Recherche...

Completed

Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease (PRO-MH2)

Huntington Disease

France
Vanderbilt University

Terminated

Magnetic Resonance Spectroscopy in Autonomic Failure

Multiple System Atrophy | Pure Autonomic Failure

United States
University of California, Davis

Completed

A Pre-Cellular Therapy Observational Study in Early Huntington's Disease (PRE-CELL)

Huntington Disease

United States
Palobiofarma SL
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Terminated

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-999 "After Multiple Oral Doses" in Healthy Volunteers

Huntington Disease

Spain
University of Rochester
Kaneka Corporation

Completed

Bioavailability of Ubiquinol in Huntington Disease

Huntington Disease

United States
Massachusetts General Hospital
National Center for Complementary and Integrative Health (NCCIH); University...

Terminated

Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) (CREST-E)

Huntington's Disease

United States, Canada, New Zealand, Australia
Children's Oncology Group
National Cancer Institute (NCI)

Withdrawn

Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder

Leukemia
Psyadon Pharma

Completed

Ecopipam Treatment of Tourette Syndrome

Tourette's Syndrome

United States
Universitaire Ziekenhuizen KU Leuven

Unknown

Functional Imaging of Social Cognition in Premanifest Huntington's Disease (FISCIP)

Huntington's Disease
Medivation, Inc.
Huntington Study Group

Completed

A Study of the Novel Drug Dimebon in Patients With Huntington's Disease (DIMOND)

Huntington's Disease

United States
Ron Postuma
Canadian Institutes of Health Research (CIHR); University of Toronto

Completed

Caffeine for Excessive Daytime Somnolence in Parkinson's Disease

Parkinson's Disease | Excessive Daytime Somnolence

Canada
McMaster University
Pfizer; Hamilton Health Sciences Corporation

Terminated

Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study) (PREGA)

Complex Regional Pain Syndromes

Canada
Teva Branded Pharmaceutical Products R&D, Inc.
H. Lundbeck A/S

Completed

Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

Multiple System Atrophy

United States, Austria, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, Portugal, Spain, United Kingdom
Charite University, Berlin, Germany
University Hospital Muenster; Ruhr University of Bochum; University of Ulm

Completed

Apathy Cure Through Bupropion in Huntington's Disease (Action-HD)

Huntington's Disease | Apathy

Germany
National Institute of Neurological Disorders and...

Terminated

Augmenting Effects of L-DOPS With Carbidopa and Entacapone

Parkinson Disease | Autonomic Nervous System Diseases | Multiple System Atrophy

United States
GTx

Completed

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

Cachexia

United States, Canada
Seoul St. Mary's Hospital

Unknown

Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy

Lymphoma | Chronic Hepatitis B
Siena Biotech S.p.A.

Completed

A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease

Huntington's Disease

United States
Heinrich-Heine University, Duesseldorf

Completed

Deep Brain Stimulation of the Globus Pallidus in Huntington's Disease

Huntington's Disease

Germany
Henri Mondor University Hospital

Completed

Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia (HCQITP)

Systemic Lupus Erythematosus | Immune Thrombocytopenia
Seoul National University Hospital
European Huntington's Disease Network

Unknown

Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)

Huntington Disease

Korea, Republic of
Siena Biotech S.p.A.

Completed

Escalating Dose Study in Healthy Volunteers With SEN0014196

Huntington's Disease

United Kingdom
University of Rochester

Completed

Effects of Music Therapy on Huntington's Disease

Huntington's Disease

United States
Yonsei University

Completed

Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy

Multiple System Atrophy

Korea, Republic of
HP Therapeutics Foundation
Huntington Study Group

Unknown

Cooperative Huntington's Observational Research Trial

Huntington Disease

United States, Canada, Australia
Johns Hopkins University

Terminated

Pilot Study of the Modified Atkins Diet for Tourette Syndrome

Tourette Syndrome

United States
National Institute of Nursing Research (NINR)

Completed

Family Health After Predictive Huntington Disease (HD) Testing

Huntington Disease

United States
Posit Science Corporation

Completed

Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment

Breast Cancer | Memory Disorders | Cognitive Symptoms

United States
National Institute of Neurological Disorders and...

Completed

Effects of Lithium and Divalproex'on Brain-Derived Neurotrophic Factor in Huntington's Disease

Huntington's Disease

United States
Medivation, Inc.
Huntington Study Group

Completed

Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease

Huntington's Disease

United States
National Center for Complementary and Integrative...

Completed

Creatine Therapy for Huntington's Disease

Huntington's Disease

United States
Prestwick Pharmaceuticals

Completed

Efficacy and Safety of Tetrabenazine in Chorea

Huntington's Disease
Yazeed Sawalha

Withdrawn

Lenalidomide, Umbralisib, and Ublituximab for the Treatment of Relapsed or Refractory Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma

Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Refractory Grade 1 Follicular... and other conditions
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni Foundation

Completed

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

Diffuse Large B-Cell Lymphoma | Acute Myeloid Leukemia | Refractory Hodgkin Lymphoma | Previously Treated Myelodysplastic Syndrome | Recurrent Mantle Cell Lymphoma | Waldenstrom Macroglobulinemia | Acute Lymphoblastic Leukemia | Refractory Plasma Cell Myeloma | Recurrent Small Lymphocytic Lymphoma | Refractory... and other conditions

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia

Recurrent Adult Burkitt Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Post-Transplant Lymphoproliferative Disorder | Recurrent Chronic Lymphocytic Leukemia | Recurrent Follicular Lymphoma and other conditions

United States
Joseph Tuscano
National Cancer Institute (NCI); Celgene

Active, not recruiting

CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell Lymphoma

Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Hairy Cell Leukemia | Refractory Mantle Cell Lymphoma | Recurrent... and other conditions

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Splenic Marginal Zone Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Cutaneous B-cell Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Adult Grade III Lymphomatoid... and other conditions

United States
Kami Maddocks
National Cancer Institute (NCI)

Completed

Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Burkitt Lymphoma | Recurrent... and other conditions

United States
Roswell Park Cancer Institute

Completed

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Primary Myelofibrosis | Polycythemia Vera | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma and other conditions

United States
M.D. Anderson Cancer Center

Recruiting

Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy

Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma | Recurrent High Grade B-Cell... and other conditions

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Recurrent Burkitt Lymphoma | Refractory Burkitt Lymphoma | High Grade B-Cell... and other conditions

United States

Clinical Trials on Submandibular Gland Neoplasms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations